Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a growing specialty pharmaceutical dermatology company, based in Canada, on pace to achieve our goal of becoming the best and most customer-centric dermatology company in North America. We are broadening our presence in Canada and aggressively building a commercial infrastructure in the United States by acquiring first- or best-in-class products and transformative compounds that fulfill high unmet medical needs. We have everything it takes – strong financials, a robust and growing product portfolio, and savvy executive leadership.  We currently market 4 brands in Canada including Epuris, Vaniqa, Actikerall and Beteflam.


Participant in Dermatology Update 2017:

27oct12:15 pm2:15 pmOzanex Advisory BoardCIPHER ADVISORY BOARD12:15 pm - 2:15 pm The Mackenzie Ballroom I

27oct2:45 pm4:00 pmPlenary Session 3Chair: Dr. Allison Sutton2:45 pm - 4:00 pm The Waterfront Ballroom C